GUESF yields 2000000.00% · PFE yields 6.13%● Live data
📍 GUESF pulled ahead of the other in Year 1
Combined, GUESF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GUESF + PFE for your $10,000?
GuestLogix Inc. provides retail and payment technology solutions to the passenger travel industry. The company offers point-of-sale (POS) hardware solutions comprising mobile, POS device, and inflight entertainment systems; retail platform solutions; and payment processing technology, as well as OnTouch destination merchandising solutions. It also provides ancillary insights services, such as out-of-the-box reporting suites, enterprise reporting toolsets, and advanced analytics; and travel retail performance management services consisting of operational process development, outsourced retail management, and retail model development services. In addition, the company offers GuestPass Ticketing, a ticketing solution that enables travel operators to facilitate ticketing services across multiple access points; and t-Retail Platform, which provides destination-based content for travel operators to use in the booking path. It primarily serves customers in North America, Europe, South America, Africa, and Asia. The company is headquartered in Toronto, Canada.
Full GUESF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.